Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Link To Carfilzomib Clinical Studies From The International Myeloma Foundation For Newly Diagnosed Or Relapsed Multiple Myeloma Patients

Home/Link To Carfilzomib Clinical Studies From The International Myeloma Foundation For Newly Diagnosed Or Relapsed Multiple Myeloma Patients

Link To Carfilzomib Clinical Studies From The International Myeloma Foundation For Newly Diagnosed Or Relapsed Multiple Myeloma Patients

Here is a link I found helpful from the International Myeloma Foundation (IMF), referencing six different research studies that are still accepting multiple myeloma patients:  Carfilzomib Treatment Studies.  As you may recall, there was a lot of excitement about carfilzomib’s potential to reduce some of the side effects associated with a similar drug, Velcade, at last Decembers ASH conference in New Orleans. Keep in mind, Velcade is already FDA approved for use in newly diagnosed as well as multiple myeloma patients who have relapsed.  But early studies have shown Carfilzomib to be effective for some refractory (relapsed and drug resistant) myeloma patients. 

Feel good and keep smiling!  Pat